Company Analysis
Sign in

Freenome, Inc. (FRNM)

Nasdaq: FRNM · Services-Medical Laboratories · New York, NY · filing with the SEC since 2024
Full chart Alerts Compare
Grade5.0
◀ Past 4.1● Present 6.1▶ Future 4.6
8 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenuen/a
Net income$837,468
Earnings per sharen/a
Operating cash flow-$864,653
Cash$865,031-23.4%
Debtn/a
Shareholders’ equity-$4.8M-126.7%
Shares, dilutedn/a
Return on equityn/a
The recordfrom its filings
Filings in 202688
Newest filingNov 13 · 424B3
Annual reportMar 12, 2026
Quarterly reportNov 12, 2026
Next report due10-K by Mar 31
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Trailing twelve months to Sep 2026Net income $109MCash from operations $82.1Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
25
As filed, in USD. Nothing here is a forecast.

News

Nov 13, 2026 · SEC EDGAR · Form 424B3
Shelf offering
Open the filing on sec.gov
Nov 12, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Nov 10, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Oct 20, 2026 · SEC EDGAR · Form 424B3
Shelf offering
Open the filing on sec.gov
Oct 20, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Sep 4, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Sep 1, 2026 · SEC EDGAR · Form SCHEDULE 13G
Large holder notice
Open the filing on sec.gov
Aug 27, 2026 · SEC EDGAR · Form EFFECT
Registration effective
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton FRNM · research, not advice